5-hydroxydecanoate has been researched along with Heart Diseases in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müllenheim, J | 1 |
| Ebel, D | 1 |
| Bauer, M | 1 |
| Otto, F | 1 |
| Heinen, A | 1 |
| Frässdorf, J | 1 |
| Preckel, B | 1 |
| Schlack, W | 1 |
1 other study available for 5-hydroxydecanoate and Heart Diseases
| Article | Year |
|---|---|
Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits.
Topics: Anesthetics, Inhalation; Animals; ATP-Binding Cassette Transporters; Blood Pressure; Coronary Vessel | 2003 |